| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |